Page last updated: 2024-10-26

diflunisal and Leukemia, Myeloid, Acute

diflunisal has been researched along with Leukemia, Myeloid, Acute in 1 studies

Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.
diflunisal : An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shirakawa, K1
Wang, L1
Man, N1
Maksimoska, J1
Sorum, AW1
Lim, HW1
Lee, IS1
Shimazu, T1
Newman, JC1
Schröder, S1
Ott, M1
Marmorstein, R1
Meier, J1
Nimer, S1
Verdin, E1

Other Studies

1 other study available for diflunisal and Leukemia, Myeloid, Acute

ArticleYear
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
    eLife, 2016, 05-31, Volume: 5

    Topics: Acetyl Coenzyme A; Acetylation; Animals; Antineoplastic Agents; Binding, Competitive; Catalytic Doma

2016